Overview and Scope
Anticoagulants refer to a drug used to prevent and treat blood clots in the heart and blood arteries. called a blood thinner as well. It is utilized to slow down the body’s clotting process. These are blood thinners, but they do not thin the blood, instead, they avoid or minimize clots or thrombi.
Sizing and Forecast
The anticoagulants market size has grown rapidly in recent years. It will grow from $45.18 billion in 2023 to $49.89 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, increased prevalence of cardiovascular diseases, rising awareness about the importance of anticoagulant therapy, expansion of indications for anticoagulant use, increased incidence of venous thromboembolism (vte) and atrial fibrillation.
The anticoagulants market size is expected to see rapid growth in the next few years. It will grow to $77.71 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to expansion of indications for novel anticoagulant drugs, rising healthcare expenditure, emergence of novel oral anticoagulants (noacs) as primary treatment options, financial support offered by central authorities to revamp healthcare facilities, expansion of the healthcare infrastructure. Major trends in the forecast period include advancements in medical technologies and diagnostic methods, integration of artificial intelligence and data analytics in anticoagulant therapy, growing emphasis on patient education and adherence programs, development of reversal agents.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report
Segmentation & Regional Insights
The anticoagulants market covered in this report is segmented –
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users
North America was the largest region in the anticoagulants market in 2023. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp
Major Driver Impacting Market Growth
The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years. CVDs (cardiovascular diseases) are a category of heart and blood vessel problems. Cardiovascular diseases (CVDs) are the primary, source of death worldwide with low- and middle-income nations accounting for three-quarters of CVD deaths. Anticoagulation pharmacotherapy known as direct oral anticoagulants is used to minimize thrombosis in a variety of cardiovascular situations. According to the World Health Organization report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Therefore, the increasing cardiovascular diseases drive the growth of the anticoagulants market.
Key Industry Players
Major companies operating in the anticoagulants market report are GlaxoSmithKline plc, Leo Pharma A/S, Alexion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Mylan N. V., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi S. A., Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca plc, Bristol-Myers Squibb Company, CSL Behring, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson, Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Natco Pharma Limited, Novartis International AG, Portola Pharmaceuticals Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Zydus Cadila Healthcare Limited
The anticoagulants market report table of contents includes:
1. Executive Summary
- Anticoagulants Market Characteristics
- Anticoagulants Market Trends And Strategies
- Anticoagulants Market – Macro Economic Scenario
- Global Anticoagulants Market Size and Growth
- Anticoagulants Market Segmentation
- Anticoagulants Market Regional And Country Analysis
…………………….
- Key Mergers And Acquisitions In The Anticoagulants Market
- Anticoagulants Market Future Outlook and Potential Analysis
- Appendix
List Of Tables :
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Anticoagulants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Anticoagulants Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Anticoagulants Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
……………
Table 75: GlaxoSmithKline plc Financial Performance
Table 76: Leo Pharma A/S Financial Performance
Table 77: Alexion Pharmaceuticals Inc. Financial Performance
Table 78: Amphastar Pharmaceuticals Inc. Financial Performance
Table 79: Bayer AG Financial Performance
Explore the trending research reports from TBRC:
https://goodprnews.com/skin-care-products-market-trend/
https://topprnews.com/smart-weapons-market-segments/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
